MedTrace Logo

Nutritional Study to Determine the Effect of Fish Oil on Atopic Dermatitis

NCT06194045 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-01-12

No results posted yet for this study

Summary

Atopic Dermatitis is associated with pronounced changes in the lipid composition in the skin. The lipid changes are influenced by and contributing to both the inflammatory circuit and the impaired barrier as well as changes in the skin microbiome This nutritional study will investigate the effect of long-chain monounsaturated fatty acid Cetoleic acid on atoptic dermatitis. Earlier studies have shown a anti-inflammatory effect of celoteic acid.

Conditions

Interventions

DIETARY_SUPPLEMENT

LC-MUFA oil

2 x 1 g capsules containing marine oil from North Atlantic fish

DIETARY_SUPPLEMENT

Placebo

2 x 1 g capsules containing corn oil

Sponsors & Collaborators

  • Helse Møre og Romsdal HF

    collaborator OTHER_GOV

  • Epax Norway AS

    collaborator INDUSTRY

  • University of Manchester

    collaborator OTHER

  • Møreforsking AS

    lead OTHER

Principal Investigators

  • Dag Arne Lihaug Hoff · Helse Møre og Romsdal HF

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-01
Primary Completion
2024-10-10
Completion
2024-10-10

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06194045 on ClinicalTrials.gov